Knowledge on the development and progression of liver fibrosis has grown ex
ponentially in the past decade. At present, liver fibrogenesis is referred
to as a dynamic process involving complex cellular and molecular mechanisms
, resulting from the chronic activation of the tissue repair mechanisms tha
t follows reiterated liver tissue injury. The identification and characteri
zation of the cell types and of the different mediators involved in this pr
ocess has allowed a "re-visitation" of several issues related to liver cirr
hosis and its immediate consequences. Among these, evaluation of the relati
onships occurring between fibrogenesis and portal hypertension, cholestasis
and the development of hepatocellular carcinoma, represent some of the hot
test areas of research in this field of hepatology. The elucidation of many
of the cellular and molecular mechanisms responsible for the progression o
f liver fibrosis has provided a sound basis for the development of pharmaco
logical strategies able to modulate this important pathophysiological proce
ss.